David H. Ellison

18.9k total citations · 5 hit papers
226 papers, 12.9k citations indexed

About

David H. Ellison is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nutrition and Dietetics. According to data from OpenAlex, David H. Ellison has authored 226 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Molecular Biology, 87 papers in Pulmonary and Respiratory Medicine and 49 papers in Nutrition and Dietetics. Recurrent topics in David H. Ellison's work include Ion Transport and Channel Regulation (128 papers), Electrolyte and hormonal disorders (57 papers) and Magnesium in Health and Disease (37 papers). David H. Ellison is often cited by papers focused on Ion Transport and Channel Regulation (128 papers), Electrolyte and hormonal disorders (57 papers) and Magnesium in Health and Disease (37 papers). David H. Ellison collaborates with scholars based in United States, United Kingdom and Germany. David H. Ellison's co-authors include James A. McCormick, Chao-Ling Yang, Heino Velázquez, Tomás Berl, Fay Wright, Arohan R. Subramanya, Robert F. Reilly, Andrew S. Terker, G. Michael Felker and Gerardo Gamba and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

David H. Ellison

217 papers receiving 12.7k citations

Hit Papers

Gitelman's variant of Barter's syndrome, inherited hypoka... 1996 2026 2006 2016 1996 2007 2015 2019 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gitelman's variant of Barter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter
    1996 894 citations David H. Ellison et al. profile →
  2. The Syndrome of Inappropriate Antidiuresis
    2007 577 citations David H. Ellison et al. profile →
  3. Potassium Modulates Electrolyte Balance and Blood Pressure through Effects on Distal Cell Voltage and Chloride
    2015 348 citations Chong Zhang, James A. McCormick et al. profile →
  4. Animal Models of Hypertension: A Scientific Statement From the American Heart Association
    2019 228 citations David H. Ellison et al. Hypertension profile →
  5. Diuretic Therapy for Patients With Heart Failure
    2020 223 citations David H. Ellison, Zachary L. Cox et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Ellison United States 64 8.2k 4.9k 2.7k 2.4k 2.1k 226 12.9k
Gerardo Gamba Mexico 60 8.8k 1.1× 2.4k 0.5× 2.7k 1.0× 1.9k 0.8× 2.8k 1.3× 229 13.2k
Shinichi Uchida Japan 51 8.0k 1.0× 2.6k 0.5× 1.5k 0.5× 1.4k 0.6× 1.2k 0.5× 272 10.1k
Manoocher Soleimani United States 55 5.6k 0.7× 2.0k 0.4× 1.4k 0.5× 958 0.4× 1.5k 0.7× 229 9.3k
Carsten A. Wagner Switzerland 68 7.4k 0.9× 2.3k 0.5× 2.0k 0.7× 1.0k 0.4× 4.4k 2.1× 324 14.6k
Volker Vallon United States 78 8.4k 1.0× 2.8k 0.6× 1.6k 0.6× 7.1k 2.9× 4.3k 2.0× 243 18.1k
Alicia A. McDonough United States 53 4.6k 0.6× 1.4k 0.3× 1.5k 0.5× 1.6k 0.7× 1.2k 0.5× 161 7.2k
Daniel G. Bichet Canada 60 7.1k 0.9× 6.4k 1.3× 705 0.3× 1.1k 0.4× 1.3k 0.6× 256 13.7k
Hermann Haller Germany 64 4.7k 0.6× 2.3k 0.5× 493 0.2× 1.4k 0.6× 2.1k 1.0× 307 14.5k
Donald E. Kohan United States 52 4.2k 0.5× 1.8k 0.4× 851 0.3× 2.6k 1.1× 1.9k 0.9× 227 10.7k
Masashi Mukoyama Japan 56 4.5k 0.6× 2.3k 0.5× 578 0.2× 1.5k 0.6× 2.2k 1.0× 259 15.3k

Countries citing papers authored by David H. Ellison

Since Specialization
Citations

This map shows the geographic impact of David H. Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Ellison more than expected).

Fields of papers citing papers by David H. Ellison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Ellison. The network helps show where David H. Ellison may publish in the future.

Co-authorship network of co-authors of David H. Ellison

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Ellison. A scholar is included among the top collaborators of David H. Ellison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Ellison. David H. Ellison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gamba, Gerardo & David H. Ellison. (2025). KS-WNK1 augments the effects of dietary potassium intake on renal sodium chloride reabsorption. Journal of Clinical Investigation. 135(15).
2.
Ellison, David H.. (2025). A novel extrarenal thiazide target may contribute to blood pressure effects. Kidney International. 108(5). 728–730. 1 indexed citations
3.
Bahena-López, Jessica Paola, Alina Smorodchenko, Xiao‐Tong Su, et al.. (2025). Distinct cell types along thick ascending limb express pathways for monovalent and divalent cation transport. JCI Insight. 10(13).
4.
Bahena-López, Jessica Paola, Norma Vázquez, Ruth Rincón-Heredia, et al.. (2024). KS-WNK1 is required for the renal response to extreme changes in potassium intake. American Journal of Physiology-Renal Physiology. 326(3). F460–F476. 6 indexed citations
5.
Rao, Veena S., Juan B. Ivey‐Miranda, Zachary L. Cox, et al.. (2023). Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects. Journal of the American Society of Nephrology. 35(2). 189–201. 21 indexed citations
6.
Su, Xiao‐Tong, Wen‐Hui Wang, Na Li, et al.. (2022). Mineralocorticoid Receptor Antagonists Cause Natriuresis in the Absence of Aldosterone. Hypertension. 79(7). 1423–1434. 24 indexed citations
7.
Cornelius, Ryan J., et al.. (2022). COP9 signalosome deletion promotes renal injury and distal convoluted tubule remodeling. American Journal of Physiology-Renal Physiology. 323(1). F4–F19. 6 indexed citations
8.
Murali, Sathish K., Robert Little, Søren Brandt Poulsen, et al.. (2021). Potassium Effects on NCC Are Attenuated during Inhibition of Cullin E3–Ubiquitin Ligases. Cells. 11(1). 95–95. 13 indexed citations
9.
Cox, Zachary L., Veena S. Rao, Juan B. Ivey‐Miranda, et al.. (2021). Compensatory post-diuretic renal sodium reabsorption is not a dominant mechanism of diuretic resistance in acute heart failure. European Heart Journal. 42(43). 4468–4477. 16 indexed citations
10.
Su, Xiao‐Tong, et al.. (2020). Distal convoluted tubule Cl−concentration is modulated via K+channels and transporters. American Journal of Physiology-Renal Physiology. 319(3). F534–F540. 39 indexed citations
11.
Cornelius, Ryan J., Catherina A. Cuevas, Jonathan W. Nelson, et al.. (2018). Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway. Journal of the American Society of Nephrology. 29(11). 2627–2640. 20 indexed citations
12.
Cornelius, Ryan J., Chong Zhang, Kayla J. Erspamer, et al.. (2018). Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension. American Journal of Physiology-Renal Physiology. 315(4). F1006–F1018. 17 indexed citations
13.
Argaiz, Eduardo R., María Chávez‐Canales, Alejandro Rodríguez Gama, et al.. (2018). Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC. American Journal of Physiology-Renal Physiology. 315(3). F734–F745. 48 indexed citations
14.
Thosar, Saurabh S., Jose Rueda, Michael Lasarev, et al.. (2018). Separate and interacting effects of the endogenous circadian system and behaviors on plasma aldosterone in humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 316(2). R157–R164. 29 indexed citations
15.
Ellison, David H.. (2017). Treatment of Disorders of Sodium Balance in Chronic Kidney Disease. Advances in Chronic Kidney Disease. 24(5). 332–341. 21 indexed citations
16.
Zhang, Xuchen, Thomas D. Schiano, Swan N. Thung, et al.. (2013). Neuropathology. Laboratory Investigation. 93. 413–420. 1 indexed citations
17.
Butts, Charles, David Bodkin, Edward L. Middleman, et al.. (2007). Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 25(36). 5777–5784. 160 indexed citations
18.
Yang, Chao-Ling, Xiaoman Zhu, Juan Wang, Arohan R. Subramanya, & David H. Ellison. (2005). Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. Journal of Clinical Investigation. 115(5). 1379–1387. 139 indexed citations
19.
Zhu, Xiaoman, et al.. (2005). Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. Journal of Clinical Investigation. 115(5). 1379–1387. 9 indexed citations
20.
Yang, Chao-Ling, Jordan Angell, Rose Mitchell, & David H. Ellison. (2003). WNK kinases regulate thiazide-sensitive Na-Cl cotransport. Journal of Clinical Investigation. 111(7). 1039–1045. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerardo Gamba Breakdown of academic impact, for papers by Shinichi Uchida Breakdown of academic impact, for papers by Manoocher Soleimani Breakdown of academic impact, for papers by Carsten A. Wagner Breakdown of academic impact, for papers by Volker Vallon Breakdown of academic impact, for papers by Alicia A. McDonough Breakdown of academic impact, for papers by Daniel G. Bichet Breakdown of academic impact, for papers by Hermann Haller Breakdown of academic impact, for papers by Donald E. Kohan Breakdown of academic impact, for papers by Masashi Mukoyama
Rankless by CCL
2026